NDAQ
56
3
JCI
42
4
SYF
55
7
HBI
46
3
DD
34
-2
EBAY
42
2
RRC
65
2
PSX
42
17
CTAS
40
-5
TDC
28
2
KO
57
-13
ADP
62
3
DHI
37
-4
HSY
50
-6
FOXA
52
2
MA
57
2
VRTX
57
4
MCK
74
-4
EA
54
-5
FTI
46
3
NDAQ
56
3
JCI
42
4
SYF
55
7
HBI
46
3
DD
34
-2
EBAY
42
2
RRC
65
2
PSX
42
17
CTAS
40
-5
TDC
28
2
KO
57
-13
ADP
62
3
DHI
37
-4
HSY
50
-6
FOXA
52
2
MA
57
2
VRTX
57
4
MCK
74
-4
EA
54
-5
FTI
46
3
Financhill
Back

Matthews Emerging Markets Equity Active ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
50

MEM
Matthews Emerging Markets Equity Active ETF

Last Price:
$29.64
Seasonality Move:
1.45%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.37
Seasonality Move:
6.73%
Sell
50
Matthews Emerging Markets Equity Active ETF (MEM) is a Sell

Is Matthews Emerging Markets Equity Active ETF a Buy, Sell or Hold?

  • The current Matthews Emerging Markets Equity Active ETF [MEM] share price is $29.69. The Score for MEM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MEM Stock Price Chart

What is Matthews Emerging Markets Equity Active ETF's stock price today?

  • The Matthews Emerging Markets Equity Active ETF share price today is $29.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEM is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

MEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.88 Sell
Chaikin Money Flow: 3817 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.56 - 30.32) Sell
Bollinger Bands (100): (29.19 - 32.31) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

MEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.71 Sell
20-day SMA: 30.01 Sell
50-day SMA: 29.46 Buy
200-day SMA: 30.8 Sell
8-day EMA: 29.8 Sell
20-day EMA: 29.83 Sell
50-day EMA: 29.94 Sell
200-day EMA: 30.29 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Matthews Emerging Markets Equity Active ETF Earnings Growth & MEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Matthews Emerging Markets Equity Active ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):